Your browser doesn't support javascript.
loading
Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
Xia, Shi-Jun; Du, Xin; Li, Chao; Wu, Jia-Hui; Tang, Ri-Bo; Chang, San-Shuai; Guo, Xue-Yuan; Yu, Rong-Hui; Long, De-Yong; Bai, Rong; Liu, Nian; Sang, Cai-Hua; Li, Song-Nan; Liu, Xiao-Hui; Pan, Jian-Hong; Dong, Jian-Zeng; Lip, Gregory Y H; Ma, Chang-Sheng.
Afiliación
  • Xia SJ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China. Electronic address: duxinheart@sina.com.
  • Li C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Wu JH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Tang RB; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Chang SS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Guo XY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Yu RH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Long DY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Li SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Liu XH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Pan JH; Peking University Clinical Research Institute, Beijing, China.
  • Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
  • Lip GY; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
  • Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China. Electronic address: chshma@vip.sina.com.
Int J Cardiol ; 220: 284-9, 2016 Oct 01.
Article en En | MEDLINE | ID: mdl-27390943

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Pautas de la Práctica en Medicina / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hiperlipidemias Tipo de estudio: Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Cardiol Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Pautas de la Práctica en Medicina / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hiperlipidemias Tipo de estudio: Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Cardiol Año: 2016 Tipo del documento: Article País de afiliación: China